Acute Malaria
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase IIa Proof of Concept Study of M5717-Pyronaridine in Adults and Adolescents With Acute Uncomplicated Plasmodium Falciparum Malaria (CAPTURE 1) (NCT05689047) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2023-03-29 |
Track Acute Malaria automatically
Every clearance here is in the API, with alerts when new ones post.